Praxis Home Retail Limited
Praxis Home Retail Limited (PRAXIS.BO) Stock Competitors & Peer Comparison
See (PRAXIS.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRAXIS.BO | ₹7.89 | -3.19% | 1.5B | 3.91 | ₹2.02 | N/A |
| ETERNAL.BO | ₹250.25 | -1.46% | 2.3T | 1042.71 | ₹0.24 | N/A |
| ZOMATO.NS | ₹215.19 | +0.00% | 2T | 286.92 | ₹0.75 | N/A |
| ZOMATO.BO | ₹215.25 | +0.00% | 2T | 377.63 | ₹0.57 | N/A |
| SWIGGY.NS | ₹307.40 | -2.10% | 798.2B | -16.51 | -₹18.62 | N/A |
| SWIGGY.BO | ₹307.35 | -2.09% | 798B | -16.49 | -₹18.64 | N/A |
| NYKAA.NS | ₹266.63 | +2.02% | 763.4B | 555.48 | ₹0.48 | N/A |
| NYKAA.BO | ₹266.60 | +1.97% | 763.3B | 555.42 | ₹0.48 | N/A |
| REDTAPE.NS | ₹124.14 | -0.61% | 68.6B | 32.33 | ₹3.84 | +0.60% |
| AVL.NS | ₹480.90 | -0.06% | 62.1B | 56.18 | ₹8.56 | +0.23% |
Stock Comparison
PRAXIS.BO vs ETERNAL.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ETERNAL.BO has a market cap of 2.3T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ETERNAL.BO trades at ₹250.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ETERNAL.BO's P/E ratio is 1042.71. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ETERNAL.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ETERNAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ETERNAL.BO's competition here
PRAXIS.BO vs ZOMATO.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ZOMATO.NS has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ZOMATO.NS trades at ₹215.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ZOMATO.NS's P/E ratio is 286.92. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.NS's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.NS's competition here
PRAXIS.BO vs ZOMATO.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ZOMATO.BO has a market cap of 2T. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ZOMATO.BO trades at ₹215.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ZOMATO.BO's P/E ratio is 377.63. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ZOMATO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ZOMATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ZOMATO.BO's competition here
PRAXIS.BO vs SWIGGY.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SWIGGY.NS has a market cap of 798.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while SWIGGY.NS trades at ₹307.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SWIGGY.NS's P/E ratio is -16.51. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.NS's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.NS's competition here
PRAXIS.BO vs SWIGGY.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SWIGGY.BO has a market cap of 798B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while SWIGGY.BO trades at ₹307.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SWIGGY.BO's P/E ratio is -16.49. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SWIGGY.BO's ROE of -0.48%. Regarding short-term risk, PRAXIS.BO is more volatile compared to SWIGGY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check SWIGGY.BO's competition here
PRAXIS.BO vs NYKAA.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, NYKAA.NS has a market cap of 763.4B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while NYKAA.NS trades at ₹266.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas NYKAA.NS's P/E ratio is 555.48. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.NS's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.NS's competition here
PRAXIS.BO vs NYKAA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, NYKAA.BO has a market cap of 763.3B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while NYKAA.BO trades at ₹266.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas NYKAA.BO's P/E ratio is 555.42. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to NYKAA.BO's ROE of +0.11%. Regarding short-term risk, PRAXIS.BO is more volatile compared to NYKAA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check NYKAA.BO's competition here
PRAXIS.BO vs REDTAPE.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, REDTAPE.NS has a market cap of 68.6B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while REDTAPE.NS trades at ₹124.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas REDTAPE.NS's P/E ratio is 32.33. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to REDTAPE.NS's ROE of +0.27%. Regarding short-term risk, PRAXIS.BO is more volatile compared to REDTAPE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check REDTAPE.NS's competition here
PRAXIS.BO vs AVL.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, AVL.NS has a market cap of 62.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while AVL.NS trades at ₹480.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas AVL.NS's P/E ratio is 56.18. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AVL.NS's ROE of +0.19%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AVL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AVL.NS's competition here
PRAXIS.BO vs RTNINDIA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, RTNINDIA.BO has a market cap of 41.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while RTNINDIA.BO trades at ₹29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas RTNINDIA.BO's P/E ratio is -10.01. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RTNINDIA.BO's ROE of -0.38%. Regarding short-term risk, PRAXIS.BO is more volatile compared to RTNINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check RTNINDIA.BO's competition here
PRAXIS.BO vs EMIL.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, EMIL.NS has a market cap of 38.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while EMIL.NS trades at ₹100.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas EMIL.NS's P/E ratio is 41.17. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.NS's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.NS's competition here
PRAXIS.BO vs EMIL.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, EMIL.BO has a market cap of 38.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while EMIL.BO trades at ₹99.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas EMIL.BO's P/E ratio is 41.14. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to EMIL.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to EMIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check EMIL.BO's competition here
PRAXIS.BO vs GARGI.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, GARGI.BO has a market cap of 8.9B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while GARGI.BO trades at ₹848.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas GARGI.BO's P/E ratio is 29.26. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to GARGI.BO's ROE of +0.29%. Regarding short-term risk, PRAXIS.BO is more volatile compared to GARGI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check GARGI.BO's competition here
PRAXIS.BO vs LOGICA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, LOGICA.BO has a market cap of 3.6B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while LOGICA.BO trades at ₹202.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas LOGICA.BO's P/E ratio is 25.89. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to LOGICA.BO's ROE of N/A. Regarding short-term risk, PRAXIS.BO is more volatile compared to LOGICA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check LOGICA.BO's competition here
PRAXIS.BO vs PANORAMA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PANORAMA.BO has a market cap of 3.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while PANORAMA.BO trades at ₹46.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PANORAMA.BO's P/E ratio is 30.96. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PANORAMA.BO's ROE of +0.20%. Regarding short-term risk, PRAXIS.BO is more volatile compared to PANORAMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check PANORAMA.BO's competition here
PRAXIS.BO vs KDML.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, KDML.BO has a market cap of 3.1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while KDML.BO trades at ₹132.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas KDML.BO's P/E ratio is 15.77. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KDML.BO's ROE of +0.16%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KDML.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KDML.BO's competition here
PRAXIS.BO vs COMPEAU.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, COMPEAU.BO has a market cap of 2.3B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while COMPEAU.BO trades at ₹381.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas COMPEAU.BO's P/E ratio is 14.37. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to COMPEAU.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is more volatile compared to COMPEAU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check COMPEAU.BO's competition here
PRAXIS.BO vs AAYUSH.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, AAYUSH.BO has a market cap of 1.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while AAYUSH.BO trades at ₹31.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas AAYUSH.BO's P/E ratio is 33.36. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to AAYUSH.BO's ROE of +0.54%. Regarding short-term risk, PRAXIS.BO is more volatile compared to AAYUSH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check AAYUSH.BO's competition here
PRAXIS.BO vs PRAXIS.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PRAXIS.NS has a market cap of 1.5B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while PRAXIS.NS trades at ₹7.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PRAXIS.NS's P/E ratio is 3.90. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS.NS's ROE of -1.13%. Regarding short-term risk, PRAXIS.BO is less volatile compared to PRAXIS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS.NS's competition here
PRAXIS.BO vs ISFT.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ISFT.NS has a market cap of 1.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ISFT.NS trades at ₹72.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ISFT.NS's P/E ratio is 9.45. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.NS's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is less volatile compared to ISFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.NS's competition here
PRAXIS.BO vs ISFT.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ISFT.BO has a market cap of 1.2B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ISFT.BO trades at ₹72.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ISFT.BO's P/E ratio is 9.44. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ISFT.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is less volatile compared to ISFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check ISFT.BO's competition here
PRAXIS.BO vs KEMP.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, KEMP.BO has a market cap of 1B. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while KEMP.BO trades at ₹945.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas KEMP.BO's P/E ratio is -91.75. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to KEMP.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to KEMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check KEMP.BO's competition here
PRAXIS.BO vs DIGIDRIVE.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DIGIDRIVE.NS has a market cap of 815.5M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while DIGIDRIVE.NS trades at ₹21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DIGIDRIVE.NS's P/E ratio is 6.56. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DIGIDRIVE.NS's ROE of +0.04%. Regarding short-term risk, PRAXIS.BO is less volatile compared to DIGIDRIVE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check DIGIDRIVE.NS's competition here
PRAXIS.BO vs ARCHIES.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ARCHIES.BO has a market cap of 523.3M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ARCHIES.BO trades at ₹15.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ARCHIES.BO's P/E ratio is -49.97. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.BO's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ARCHIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.BO's competition here
PRAXIS.BO vs ARCHIES.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, ARCHIES.NS has a market cap of 518.2M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while ARCHIES.NS trades at ₹15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas ARCHIES.NS's P/E ratio is -49.48. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to ARCHIES.NS's ROE of -0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to ARCHIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check ARCHIES.NS's competition here
PRAXIS.BO vs PACE.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PACE.BO has a market cap of 338.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while PACE.BO trades at ₹15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PACE.BO's P/E ratio is 8.26. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PACE.BO's ROE of +0.05%. Regarding short-term risk, PRAXIS.BO is less volatile compared to PACE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PACE.BO's competition here
PRAXIS.BO vs DUKEOFS.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DUKEOFS.BO has a market cap of 171.9M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while DUKEOFS.BO trades at ₹17.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DUKEOFS.BO's P/E ratio is -7.68. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DUKEOFS.BO's ROE of -0.12%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DUKEOFS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DUKEOFS.BO's competition here
PRAXIS.BO vs DDIL.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DDIL.BO has a market cap of 154.8M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while DDIL.BO trades at ₹3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DDIL.BO's P/E ratio is 5.31. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DDIL.BO's ROE of +0.13%. Regarding short-term risk, PRAXIS.BO is more volatile compared to DDIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check DDIL.BO's competition here
PRAXIS.BO vs UHZAVERI.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, UHZAVERI.BO has a market cap of 137.6M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while UHZAVERI.BO trades at ₹13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas UHZAVERI.BO's P/E ratio is 345.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to UHZAVERI.BO's ROE of +0.00%. Regarding short-term risk, PRAXIS.BO is more volatile compared to UHZAVERI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check UHZAVERI.BO's competition here
PRAXIS.BO vs DARSHANORNA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, DARSHANORNA.BO has a market cap of 131.4M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while DARSHANORNA.BO trades at ₹2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas DARSHANORNA.BO's P/E ratio is 22.67. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to DARSHANORNA.BO's ROE of +0.03%. Regarding short-term risk, PRAXIS.BO is less volatile compared to DARSHANORNA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check DARSHANORNA.BO's competition here
PRAXIS.BO vs RAJPUTANA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, RAJPUTANA.BO has a market cap of 104.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while RAJPUTANA.BO trades at ₹34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas RAJPUTANA.BO's P/E ratio is 43.59. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to RAJPUTANA.BO's ROE of +0.06%. Regarding short-term risk, PRAXIS.BO is more volatile compared to RAJPUTANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check RAJPUTANA.BO's competition here
PRAXIS.BO vs VEERKRUPA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, VEERKRUPA.BO has a market cap of 78.6M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while VEERKRUPA.BO trades at ₹0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas VEERKRUPA.BO's P/E ratio is 30.00. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to VEERKRUPA.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is less volatile compared to VEERKRUPA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check VEERKRUPA.BO's competition here
PRAXIS.BO vs HARIAEXPO.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, HARIAEXPO.BO has a market cap of 75.2M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while HARIAEXPO.BO trades at ₹6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas HARIAEXPO.BO's P/E ratio is 54.25. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to HARIAEXPO.BO's ROE of +0.01%. Regarding short-term risk, PRAXIS.BO is more volatile compared to HARIAEXPO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check HARIAEXPO.BO's competition here
PRAXIS.BO vs MHSGRMS.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, MHSGRMS.BO has a market cap of 52.7M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while MHSGRMS.BO trades at ₹6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas MHSGRMS.BO's P/E ratio is 7.88. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to MHSGRMS.BO's ROE of -2.38%. Regarding short-term risk, PRAXIS.BO is more volatile compared to MHSGRMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check MHSGRMS.BO's competition here
PRAXIS.BO vs JSHL.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, JSHL.BO has a market cap of 52.4M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while JSHL.BO trades at ₹8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas JSHL.BO's P/E ratio is -11.88. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to JSHL.BO's ROE of -0.02%. Regarding short-term risk, PRAXIS.BO is more volatile compared to JSHL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PRAXIS.BO.Check JSHL.BO's competition here
PRAXIS.BO vs SPECTRA.BO Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, SPECTRA.BO has a market cap of 39.1M. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while SPECTRA.BO trades at ₹5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas SPECTRA.BO's P/E ratio is -1.59. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to SPECTRA.BO's ROE of +0.07%. Regarding short-term risk, PRAXIS.BO is less volatile compared to SPECTRA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check SPECTRA.BO's competition here
PRAXIS.BO vs PRAXIS-RE.NS Comparison February 2026
PRAXIS.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRAXIS.BO stands at 1.5B. In comparison, PRAXIS-RE.NS has a market cap of 0. Regarding current trading prices, PRAXIS.BO is priced at ₹7.89, while PRAXIS-RE.NS trades at ₹15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRAXIS.BO currently has a P/E ratio of 3.91, whereas PRAXIS-RE.NS's P/E ratio is N/A. In terms of profitability, PRAXIS.BO's ROE is -1.13%, compared to PRAXIS-RE.NS's ROE of N/A. Regarding short-term risk, PRAXIS.BO is less volatile compared to PRAXIS-RE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PRAXIS.BO.Check PRAXIS-RE.NS's competition here